Safety of endovascular treatment beyond the 6-h time window in 205 patients

European Journal of Neurology

Volumn 20, Issue 6, 2013, Pages 865-871

  Jung, S ^a   Gralla, J ^a   Fischer, U ^a   Mono, M L ^a   Weck, A ^a   Ludi R ^a   Heldner, M R ^a   Findling, O ^a   El Koussy, M ^a   Brekenfeld, C ^a   Schroth, G ^a   Mattle, H P ^a   Arnold, M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Endovascular treatment; Intra arterial thrombolysis; Outcome; Unclear onset stroke; Wake up stroke

Indexed keywords

ACETYLSALICYLIC ACID; UROKINASE;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; SAFETY; VERTEBRAL ARTERY STENOSIS;

AGED; ENDOVASCULAR PROCEDURES; FEMALE; HEMORRHAGE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84877653970     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12069     Document Type: Article

References (36)

1. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
2. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The proact ii study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999; 282: 2003-2011.
3. Nadeau JO, Fang J, Kapral MK, Silver FL, Hill MD. Outcome after stroke upon awakening. Can J Neurol Sci 2005; 32: 232-236.
4. Fink JN, Kumar S, Horkan C, et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002; 33: 988-993.
5. American Heart Association and Center of Disease Control and Prevention. Heart Disease and Stroke Statistics. 2009. http://www.americanheart.org/presenter.jhtml?identifier=3037327
6. California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology 2005; 64: 654-659.
7. Barnwell SL, Clark WM, Nguyen TT, O'Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. Am J Neuroradiol 1994; 15: 1817-1822.
8. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 2010; 41: 1996-2000.
9. Gönner F, Remonda L, Mattle H, et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998; 29: 1894-1900.
10. Arnold M, Nedeltchev K, Schroth G, et al. Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004; 75: 857-862.
11. Galimanis A, Jung S, Mono ML, et al. Endovascular therapy of 623 patients with anterior circulation stroke. Stroke 2012; 43: 1052-1057.
12. Jung S, Mono ML, Fischer U, et al. Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis. Stroke 2011; 42: 1946-1951.
13. Harrington T, Roche J. The dense basilar artery as a sign of basilar territory infarction. Australas Radiol 1993; 37: 375-378.
14. Brandt T, Von Kummer R, Müller-Küppers M, Hacke W. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996; 27: 875-881.
15. Arnold M, Schroth G, Nedeltchev K, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002; 33: 1828-1833.
16. The Thrombolysis in Myocardial Infarction (TIMI) Trial. Phase I findings. TIMI Study Group. N Engl J Med 1985; 312: 932-936.
17. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001; 57: 1603-1610.
18. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
19. European Stroke Initiative Executive Committee; EUSI Writing Committee, Olsen TS, Langhorne P, Diener HC, et al. European Stroke Initiative Recommendations for Stroke Management - update 2003. Cerebrovasc Dis 2003; 16: 311-337.
20. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
21. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
22. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761-2768.
23. Smith WS, Sung G, Starkman S, et al. MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36: 1432-1438.
24. Janjua N, El-Gengaihy A, Pile-Spellman J, Qureshi AI. Late endovascular revascularization in acute ischemic stroke based on clinical-diffusion mismatch. Am J Neuroradiol 2009; 30: 1024-1027.
25. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (dias-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009; 8: 141-150.
26. Nogueira RG, Liebeskind DS, Gupta R, et al. DWI/PWI and CTP assessment in the triage of wake-up and late presenting strokes undergoing neurointervention: the DAWN trial. Presented at the International Stroke Conference, San Diego, CA 2009; 17-20.
27. Cho AH, Sohn SI, Han MK, et al. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008; 25: 572-579.
28. Serena J, Dávalos A, Segura T, Mostacero E, Castillo J. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis 2003; 16: 128-133.
29. Nadeau JO, Fang J, Kapral MK, Silver FL, Hill MD, Registry of the Canadian Stroke Network. Outcome after stroke upon awakening. Can J Neurol Sci 2005; 32: 232-236.
30. Hellier KD, Hampton JL, Guadagno JV, et al. Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry 2006; 77: 417-419.
31. Iosif C, Oppenheim C, Trystram D, Domigo V, Meder JF. MR imaging-based decision in thrombolytic therapy for stroke on awakening: report of 2 cases. Am J Neuroradiol 2008; 29: 1314-1316.
32. Barreto AD, Martin-Schild S, Hallevi H, et al. Thrombolytic therapy for patients who wake-up with stroke. Stroke 2009; 40: 827-832.
33. Adams HP Jr, Leira EC, Torner JC, et al. Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial. Stroke 2008; 39: 3277-3282.
34. Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998; 29: 992-996.
35. Todo K, Moriwaki H, Saito K, Tanaka M, Oe H, Naritomi H. Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis 2006; 21: 367-371.
36. Thomalla G, Cheng B, Ebinger M, et al. for the STIR and VISTA Imaging Investigators. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4-5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 2011; 10: 978-986.